Mercer Global Advisors Inc Biogen Inc. Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Biogen Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 5,696 shares of BIIB stock, worth $904,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,696

Previous 6,326 9.96%

Holding current value

$904,012

Previous $1.47 Million 24.69%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $119,114 - $149,184	-630 Reduced 9.96%	5,696 $1.1 Million
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $347,699 - $432,014	-1,825 Reduced 22.39%	6,326 $1.47 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $95,196 - $120,201	449 Added 5.83%	8,151 $1.76 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $608,783 - $732,815	-2,735 Reduced 26.2%	7,702 $1.99 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $2.24 Million - $2.53 Million	-8,835 Reduced 45.84%	10,437 $2.68 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $3.32 Million - $3.83 Million	-12,048 Reduced 38.47%	19,272 $5.49 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $4.3 Million - $4.9 Million	16,763 Added 115.15%	31,320 $8.71 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $2.86 Million - $3.47 Million	11,310 Added 348.32%	14,557 $4.03 Million
Q3 2022 Nov 15, 2022	SELL	$194.69 - $268.46 $27,061 - $37,315	-139 Reduced 4.11%	3,247 $867,000
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $46,509 - $55,308	-248 Reduced 6.82%	3,386 $691,000
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $125,562 - $158,202	-648 Reduced 15.13%	3,634 $765,000
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $91,807 - $117,985	410 Added 10.59%	4,282 $1.03 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $113,478 - $147,989	401 Added 11.55%	3,872 $1.1 Million
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $31,080 - $49,765	120 Added 3.58%	3,471 $1.2 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $325,553 - $381,404	-1,340 Reduced 28.57%	3,351 $937,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $3.95 Million - $5.95 Million	-16,723 Reduced 78.09%	4,691 $1.15 Million
Q3 2020 Dec 10, 2020	BUY	$264.77 - $305.71 $176,866 - $204,214	668 Added 3.22%	21,414 $6.08 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $1.15 Million - $1.52 Million	4,451 Added 27.32%	20,746 $5.55 Million
Q1 2020 May 18, 2020	BUY	$268.85 - $341.04 $3.56 Million - $4.52 Million	13,242 Added 433.74%	16,295 $5.16 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $94,625 - $130,750	-430 Reduced 12.35%	3,053 $906,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $21,309 - $23,900	98 Added 2.9%	3,483 $810,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $42,103 - $46,410	-192 Reduced 5.37%	3,385 $792,000
Q1 2019 Apr 23, 2019	BUY	$216.71 - $338.96 $234,046 - $366,076	1,080 Added 43.25%	3,577 $846,000
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $541,124 - $846,383	2,497 New	2,497 $751,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Biogen Inc. Transaction History